India’s Covid-19 case tally crosses 57-lakh mark with a spike of 86,508 new cases and 1,129 deaths in last 24 hours. The country now has 9,66,382 active cases, 46,74,988 paitents have been either cured/discharged or have migrated.
The death toll also climbed from 90,020 to 91,149 during the same period, latest data released by the Ministry of Health and Family Welfare suggested.
With complaints of shortage of Remdesivir injection and the drug being sold in black markets in the city, the Maharashtra government has directed the concerned pharmaceutical companies to make available sufficient quantity, as per requirement of injections, for treatment of patients. The government has also directed that only Rs 2,200 can be charged for each vial of Remdesivir injection.
Vaccine major Bharat Biotech has entered into a licensing agreement with the Washington University School of Medicine in St Louis (WashU). The deal has been struck for developing, conducting clinical trials, manufacturing and distributing a novel chimp-adenovirus, single dose intranasal vaccine candidate for Covid-19.
Today is the 185th day since India implemented a nationwide lockdown, to help curb the novel coronavirus pandemic. So far, India has recorded 57,32,518 confirmed COVID-19 cases, including 91,149 deaths. Maharashtra, Andhra Pradesh and Tamil Nadu have reported the highest number of cases.
However, infections are rising rapidly in states like Karnataka, Uttar Pradesh and West Bengal. Yet, India’s recovery rate continues to rise and now stands at 80.1 percent.
The Indian Council of Medical Research (ICMR) has said that 6,74,36,031 samples were tested for COVID-19 in the country till yesterday (September 23). Of these, 11,56,569 were tested yesterday.